Small Businesses |
|
|
Clinical Trial: Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed
This study is no longer recruiting patients.
|
Purpose
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Randomized phase III trial to compare cisplatin and etoposide with no chemotherapy in treating patients who have stage I, stage II, or stage IIIA non-small cell lung cancer that has been surgically removed.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| stage I non-small cell lung cancer stage II non-small cell lung cancer stage IIIA non-small cell lung cancer | Drug: cisplatin Drug: etoposide Procedure: adjuvant therapy Procedure: chemotherapy | Phase III |
MedlinePlus related topics: Lung Cancer
Study Type: Interventional
Study Design: Treatment
Official Title: Phase III Adjuvant Study of Cisplatin and Etoposide Combination for Stages I, II, and IIIA Non-Small Cell Lung Cancer
OBJECTIVES:
- Assess the efficacy of the combination of cisplatin and etoposide after radical surgery in prolonging the relapse free and overall survival for stages I, II, and IIIA non-small cell lung cancer.
OUTLINE: This a randomized study (treatment vs no treatment). Patients are stratified according to sex and to stage of disease (I vs II vs IIIA).
Patient receives cisplatin and etoposide on days 1-3, every 28 days, for 3 cycles. Patient may receive radiation therapy after surgery at the discretion of the physician.
PROJECTED ACCRUAL: Approximately 750 patients will be accrued over 3 years.
Eligibility
Ages Eligible for Study: up to 70 Years, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Histologically proven stage I, II, or IIIA non-small cell lung cancer after radical surgery
- No evidence of lymphonodal enlargement during postsurgical chest CT scan
PATIENT CHARACTERISTICS: Age:
- 70 and under
Performance status:
- ECOG 0-2
Life expectancy:
- Not specified
Hematopoietic:
- WBC at least 3,500/mm3
- Platelet count at least 100,000/mm3
Hepatic:
- Not specified
Renal:
- Creatinine no greater than 1.5 times the upper limit of normal
Pulmonary:
- FEV1 at least 1 liter
Other:
- Less than 10% weight loss in the past 3 months
- No prior malignancy except nonmelanoma skin cancer or carcinoma in situ of the cervix
PRIOR CONCURRENT THERAPY: Biologic therapy:
- Not specified
Chemotherapy:
- Not specified
Endocrine therapy:
- Not specified
Radiotherapy:
- Not specified
Surgery:
- Radical surgery required
Location Information
Greece
George Papanicolaou General Hospital, THESSALONIKI, 57010, Greece
Italy
ASL NO. 1 Imperiese, San Remo, 18038, Italy
Azienda Ospedaliera di Padova, Padova (Padua), 35128, Italy
Azienda Ospedaliera S. Maria, Terni, 05100, Italy
Azienda Ospedaliera, Reggio Emilia, 42100, Italy
Azienda Policlinico Umberto Primo, Rome, 00161, Italy
Azienda USSL No 4, Saronno, 21047, Italy
Azienda USSL NO 8, Merate, 22055, Italy
Carlo Poma Hospital, Mantova, 46100, Italy
Casa di Cura S. Maria, Varese, 21100, Italy
Casa Di Cura San Ambrogio, Milano, 20149, Italy
Cattedra di Immunologia Clinica, Turin (TO), 10128, Italy
Cattedra di Oncologia Medica - Universita degli Studi di Cagliari, Cagliari, 09124, Italy
Clinica Universita, Torino, 10126, Italy
Consorzio Mario Negri Sud, Santa Maria Imbaro, 66030, Italy
Consorzio Provinciale Antitubercolare, Milano, 20124, Italy
Dispensario Igiene Sociale, Toino, 10100, Italy
Federico II University Medical School, Naples (Napoli), 80131, Italy
Instituto Di Oncologia, Messina, 98122, Italy
Istituti Fisioterapici Ospitalieri - Roma, Rome, 00128, Italy
Istituto Clinica Medica, Sassari, 07100, Italy
Istituto Di Science Biomediche San Paolo, Milano, 20142, Italy
Istituto Nazionale per la Ricerca sul Cancro, Genoa (Genova), 16132, Italy
Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples, 80131, Italy
Istituto Scientifico H.San Raffaele, Milano, 20132, Italy
Istituto Tumori/Fondazione Pascale, Naples (Napoli), 80131, Italy
Nuovo Ospedale San Gerardo, Monza, 20052, Italy
Ospedale Agnelli, Pinerolo, 10064, Italy
Ospedale Alessandro Manzoni, Lecco, 23900, Italy
Ospedale Bassini, Balsamo Cinisello, 20092, Italy
Ospedale C. Ascalesi, Napoli, 80139, Italy
Ospedale Carlo Forlanini, Rome, 00149, Italy
Ospedale Cattinara, Trieste, Italy
Ospedale Civico E Benefratelli, Palermo, 90127, Italy
Ospedale Civile Asilo Vittoria, Mortara, 27036, Italy
Ospedale Civile Cosenza, Cosenza, 87100, Italy
Ospedale Civile Feltre, Feltre, 32100, Italy
Ospedale Civile Negrar, Negrar, 37024, Italy
Ospedale Civile Rho, Rho, 20017, Italy
Ospedale Civile Umberto I, Mestre, 30174, Italy
Ospedale Di Conselice, Conselice, 48017, Italy
Ospedale Di Gorgonzola, Gorgonzola, 20064, Italy
Ospedale Di Predabissi Melegnano, Melegnano, 20077, Italy
Ospedale Galliera Oncologia, Genova (Genoa), 16128, Italy
Ospedale General Regional Ca Foncello, Treviso, 31100, Italy
Ospedale Generale Prov. Boldrini, Thiene, 36016, Italy
Ospedale Legnago USSL 21, Legnago, 37045, Italy
Ospedale Luigi Sacco, Milano (Milan), 20157, Italy
Ospedale Maggiore Ca'Granda, Milano (Milan), 20162, Italy
Ospedale Maggiore Crema, Crema, 26013, Italy
Ospedale Maggiore dell' Universita, Trieste, 34100, Italy
Ospedale Maggiore Lodi, Lodi, I-20075, Italy
Ospedale Maggiore Parma, Parma, 43100, Italy
Ospedale Oncologico A. Businco, Cagliari, 09121, Italy
Ospedale S. Camillo-Forlanini, Rome, 00152, Italy
Ospedale S. Chiara, Trento, 38100, Italy
Ospedale San Bortolo, Vicenza, 36100, Italy
Ospedale San Carlo Borromeo, Milano (Milan), 20153, Italy
Ospedale San Filippo Neri, Rome, 00135, Italy
Ospedale San Giuseppe, Milano, 20100, Italy
Ospedale San Isidoro, Trescore Balneario, 24069, Italy
Ospedale San Martino/Cliniche Universitarie Convenzionate, Genoa (Genova), 16132, Italy
Ospedale San Michele, Cagliari, 09134, Italy
Ospedale Sant Anna, Como, 22100, Italy
Ospedale Santa Croce, Moncalieri, 10024, Italy
Ospedale Santa Croce, Cuneo, 12100, Italy
Ospedale Sesto San Giovanni, Sesto San Giovanni, 20099, Italy
Ospedale Silvestrini, Perugia, 06132, Italy
Ospedale Sta. Maria Delle Croci, Ravenna, 48100, Italy
Ospedale Torrette University Ancona, Parma, 43100, Italy
Ospedale Umberto I, Lugo DI Romagna, 48022, Italy
Ospedale Valduce, Como, 22100, Italy
Ospedale Vincenzo Monaldi, Napoli, 80131, Italy
Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore, Rome, 00168, Italy
Policlinico di Careggi, Firenze (Florence), 50134, Italy
Policlinico Militare Celio, Rome, 00184, Italy
Spedali Civili, Brescia, 25124, Italy
U.S.L. 10 Villa Ognissanti, Firenze, 50139, Italy
U.S.S.L. 72 Magenta, Magenta, 20013, Italy
Universita Degli Studi di Bari Policlinico, Bari, 70124, Italy
Universita Degli Studi di Firenze - Policlin. di Careggi, Firenze (Florence), 1 (50134), Italy
Universita Degli Studi di Udine, Udine, 33100, Italy
Universita di Ferrara, Ferrara, 44100, Italy
Universita di Torino, Torino, 10126, Italy
University of Padua, Padua, 35128, Italy
Korea, Republic of
Inha University Hospital, Incheon, Korea, Republic of
Antonio Nicolucci, MD, Study Chair, Consorzio Mario Negri Sud
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: February 2004
Last Updated: October 13, 2004
Record first received: November 1, 1999
ClinicalTrials.gov Identifier: NCT00003053
Health Authority: Unspecified
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Small Businesses (Centers for Disease Control and Prevention)

Not Signed In -

